Clinical ResearchInterventional CardiologyPrognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
Key Words
Abbreviations and Acronyms
Cited by (0)
The study was supported by the Cardiovascular Research Foundation and with grant support from Boston Scientific and Medicines Company. Dr. Mehran has received lecture fees from Boston Scientific and The Medicines Company; is a consultant to/on the advisory board of Abbott Vascular, AstraZeneca, Ortho McNeil, and Regado Biosciences; and has received a research grant from BMS/Sanofi-Aventis. Dr. Dangas reports receiving lecture fees from Abbott Vascular, AstraZeneca, Cordiva, Cordis, and The Medicines Company; consulting fees from Regado Biosciences; and research suppport from BMS/Sanofi-Aventis. Dr. Nikolsky is a consultant for Medtronic Cardiovasular. Dr. Gersh has received consulting fees from or serving on advisory boards for AstraZeneca, Bristol-Myers Squibb, Abbott Laboratories, Boston Scientific, Ortho-McNeil Janssen Scientific Affairs, Amorcyte, GE Healthcare, St. Jude Medical Inc., Medispec Limited, and Merck & Co.; and has equity interest in CV Therapeutics. Dr. Wong is a member of the Medical Advisory Board of Boston Scientific. Dr. Witzenbichler has received lecture fees from Boston Scientific and The Medicines Company. Dr. Guagliumi has received consulting fees from or has served on advisory boards for Abbott Vascular, Boston Scientific, Volcano, and Cordis; and receives grant support from Medtronic, Boston Scientific, Abbott, Lightlab, and Labcoat. Dr. Dudek reports receiving lecture fees from Nycomed; and research grants from or served as consultant/advisory board member for Abbott, Adamed, Biotronik, Balton, Bayer, BBRaun, BioMatrix, Boston Scientific, Boehringer Ingelheim, Bristol-Myers Squibb, Cordis, Cook, Eli Lilly, EuroCor, GlaxoSmithKline, Invatec, Medtronic, The Medicines Company, MSD, Nycomed, Orbus-Reich, Pfizer, Possis, Promed, Sanofi-Aventis, Siemens, Solvay, Terumo, and Tyco. Drs. Fahy and Lansky report being employed by the Cardiovascular Research Foundation. Dr. Stone reports receiving consulting fees from Medtronic, GlaxoSmithKline, Eli Lilly, and Bristol-Myers Squibb, and grant support from Boston Scientific, The Medicines Company, and Abbott Vascular. All other authors have reported that there are no relationships to disclose.